Zimmer to suspend share repuchase program to preserve funding for transaction Consequently, the company expects fully diluted share count to be approximately 171.5M shares in Q2 and 172M in the full year. Comments taken from Q1 earnings conference call.
BIOLASE CEO Jeffrey Nugent to step down, Harold Flynn appointed CEO BIOLASE (BIOL) announced that Harold Flynn Jr. will become president and CEO, effective July 13. The current president and CEO Jeffrey Nugent will step down at that time. Since 2007, Flynn has been president of Zimmer Dental, a manufacturer and provider of medical devices for the dental market. Zimmer Dental is a division of Zimmer Holdings (ZMH).